melatonin has been researched along with olanzapine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dittmann, RW; Hiemke, C; Linde, I; Mann, K; Müller, MJ; Müller-Siecheneder, F; Pott, T; Rossbach, W | 1 |
| Burke, BL; Crites, NJ; Raskind, MA; Rasmussen, DD; Tapp, AM | 1 |
| Short, MR; Winstead, PS | 1 |
| Weber, K | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Ashrafi, M; Heidari, P; Modabbernia, A; Modabbernia, MJ; Roshan, ZA; Sobhani, A; Soleimani, R; Taslimi, S | 1 |
| Hanft, A; Turkel, SB | 1 |
| Akhondzadeh, S; Hamedi, M; Keshavarzi, M; Mohammadi, MR; Mostafavi, A; Solhi, M | 1 |
| Basualdo, M; Benítez-King, G; Buijs, FN; Buijs, RM; Escobar, C; Heinze, G; Perusquía, M; Romo-Nava, F; Valdés-Tovar, M | 1 |
| Akhondzadeh, S; Mohammadi, MR; Mostafavi, SA; Solhi, M | 1 |
| Hardman, MI; Sprung, J; Weingarten, TN | 1 |
| Osler, M; Rosenqvist, TW; Wium-Andersen, IK; Wium-Andersen, MK | 1 |
5 review(s) available for melatonin and olanzapine
| Article | Year |
|---|---|
Delirium dilemma.
Topics: Antioxidants; Antipsychotic Agents; Benzodiazepines; Delirium; Haloperidol; Hospitalization; Humans; Incidence; Melatonin; Olanzapine; Risk Factors | 2007 |
Asperger's syndrome: from hiding to thriving.
Topics: Adaptation, Psychological; Asperger Syndrome; Benzodiazepines; Causality; Central Nervous System Depressants; Child; Child Behavior; Diagnosis, Differential; Early Diagnosis; Fluvoxamine; Humans; Interpersonal Relations; Melatonin; Nurse Practitioners; Nursing Assessment; Olanzapine; Prevalence; Primary Health Care; Prognosis; Psychological Tests; Psychology, Child; Risperidone; Serotonin Agents; Social Behavior; United States | 2008 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
The pharmacologic management of delirium in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Delirium; Dexmedetomidine; Dibenzothiazepines; Humans; Melatonin; Olanzapine; Quetiapine Fumarate; Risperidone | 2014 |
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2019 |
4 trial(s) available for melatonin and olanzapine
| Article | Year |
|---|---|
Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.
Topics: Adrenocorticotropic Hormone; Adult; Antipsychotic Agents; Benzodiazepines; Circadian Rhythm; Growth Hormone; Humans; Hydrocortisone; Inpatients; Male; Melatonin; Olanzapine; Prolactin; Schizophrenia; Sleep; Testosterone | 2006 |
Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antioxidants; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Melatonin; Metabolic Diseases; Middle Aged; Olanzapine; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Lipids; Lithium Carbonate; Male; Melatonin; Olanzapine; Sex Factors | 2014 |
Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; Child; Double-Blind Method; Humans; Lithium Carbonate; Male; Melatonin; Olanzapine; Psychiatric Status Rating Scales; Time Factors; Weight Gain | 2017 |
4 other study(ies) available for melatonin and olanzapine
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Energy Metabolism; Female; Lipid Metabolism; Melatonin; Obesity; Olanzapine; Pineal Gland; Rats; Rats, Sprague-Dawley; Schizophrenia; Up-Regulation; Weight Gain | 2007 |
Olanzapine-induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin.
Topics: Animals; Benzodiazepines; Biological Clocks; Central Nervous System Depressants; Hemodynamics; Immunohistochemistry; Male; Melatonin; Nucleus Accumbens; Olanzapine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Suprachiasmatic Nucleus; Ventral Tegmental Area | 2017 |
Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study.
Topics: Benzodiazepines; Denmark; Drug Prescriptions; Drug Utilization; Female; Humans; Hypnotics and Sedatives; Male; Melatonin; Mianserin; Mirtazapine; Olanzapine; Pregabalin; Promethazine; Quetiapine Fumarate; Substance-Related Disorders | 2023 |